You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global and United States Post herpetic Neuralgia Treatment Market Size, Status and Forecast 2021-2027

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.
North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.
In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.
Market Analysis and Insights: Global Post herpetic Neuralgia Treatment Market
The global Post herpetic Neuralgia Treatment market size is projected to reach US$ 2002.2 million by 2027, from US$ 1507 million in 2020, at a CAGR of 4.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Post herpetic Neuralgia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Post herpetic Neuralgia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Post herpetic Neuralgia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Post herpetic Neuralgia Treatment market.
Post herpetic Neuralgia Treatment Breakdown Data by Type
Skin Patch
Post herpetic Neuralgia Treatment Breakdown Data by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Based on regional and country-level analysis, the Post herpetic Neuralgia Treatment market has been segmented as follows:
North America
United States
Rest of Europe
South Korea
Southeast Asia
Rest of Asia-Pacific
Latin America
Middle East & Africa
Saudi Arabia
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Post herpetic Neuralgia Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.

The following players are covered in this report:
Arbor Pharma
Assertio Therapeutics
Endo Pharma
Teikoku Pharma
Hengrui Medicine

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anticonvulsants
1.2.3 Skin Patch
1.2.4 Other
1.3 Market by Application
1.3.1 Global Post herpetic Neuralgia Treatment Market Share by Distribution Channel: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Post herpetic Neuralgia Treatment Market Perspective (2016-2027)
2.2 Post herpetic Neuralgia Treatment Growth Trends by Regions
2.2.1 Post herpetic Neuralgia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Post herpetic Neuralgia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Post herpetic Neuralgia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Post herpetic Neuralgia Treatment Industry Dynamic
2.3.1 Post herpetic Neuralgia Treatment Market Trends
2.3.2 Post herpetic Neuralgia Treatment Market Drivers
2.3.3 Post herpetic Neuralgia Treatment Market Challenges
2.3.4 Post herpetic Neuralgia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Post herpetic Neuralgia Treatment Players by Revenue
3.1.1 Global Top Post herpetic Neuralgia Treatment Players by Revenue (2016-2021)
3.1.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Post herpetic Neuralgia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Post herpetic Neuralgia Treatment Revenue
3.4 Global Post herpetic Neuralgia Treatment Market Concentration Ratio
3.4.1 Global Post herpetic Neuralgia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post herpetic Neuralgia Treatment Revenue in 2020
3.5 Post herpetic Neuralgia Treatment Key Players Head office and Area Served
3.6 Key Players Post herpetic Neuralgia Treatment Product Solution and Service
3.7 Date of Enter into Post herpetic Neuralgia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Post herpetic Neuralgia Treatment Breakdown Data by Type
4.1 Global Post herpetic Neuralgia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Post herpetic Neuralgia Treatment Forecasted Market Size by Type (2022-2027)

5 Post herpetic Neuralgia Treatment Breakdown Data by Distribution Channel
5.1 Global Post herpetic Neuralgia Treatment Historic Market Size by Distribution Channel (2016-2021)
5.2 Global Post herpetic Neuralgia Treatment Forecasted Market Size by Distribution Channel (2022-2027)

6 North America
6.1 North America Post herpetic Neuralgia Treatment Market Size (2016-2027)
6.2 North America Post herpetic Neuralgia Treatment Market Size by Type
6.2.1 North America Post herpetic Neuralgia Treatment Market Size by Type (2016-2021)
6.2.2 North America Post herpetic Neuralgia Treatment Market Size by Type (2022-2027)
6.2.3 North America Post herpetic Neuralgia Treatment Market Size by Type (2016-2027)
6.3 North America Post herpetic Neuralgia Treatment Market Size by Distribution Channel
6.3.1 North America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2021)
6.3.2 North America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2022-2027)
6.3.3 North America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2027)
6.4 North America Post herpetic Neuralgia Treatment Market Size by Country
6.4.1 North America Post herpetic Neuralgia Treatment Market Size by Country (2016-2021)
6.4.2 North America Post herpetic Neuralgia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Post herpetic Neuralgia Treatment Market Size (2016-2027)
7.2 Europe Post herpetic Neuralgia Treatment Market Size by Type
7.2.1 Europe Post herpetic Neuralgia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Post herpetic Neuralgia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Post herpetic Neuralgia Treatment Market Size by Type (2016-2027)
7.3 Europe Post herpetic Neuralgia Treatment Market Size by Distribution Channel
7.3.1 Europe Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2021)
7.3.2 Europe Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2022-2027)
7.3.3 Europe Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2027)
7.4 Europe Post herpetic Neuralgia Treatment Market Size by Country
7.4.1 Europe Post herpetic Neuralgia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Post herpetic Neuralgia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Type
8.2.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Distribution Channel
8.3.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2021)
8.3.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2022-2027)
8.3.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2027)
8.4 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region
8.4.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Post herpetic Neuralgia Treatment Market Size (2016-2027)
9.2 Latin America Post herpetic Neuralgia Treatment Market Size by Type
9.2.1 Latin America Post herpetic Neuralgia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Post herpetic Neuralgia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Post herpetic Neuralgia Treatment Market Size by Type (2016-2027)
9.3 Latin America Post herpetic Neuralgia Treatment Market Size by Distribution Channel
9.3.1 Latin America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2021)
9.3.2 Latin America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2022-2027)
9.3.3 Latin America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2027)
9.4 Latin America Post herpetic Neuralgia Treatment Market Size by Country
9.4.1 Latin America Post herpetic Neuralgia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Post herpetic Neuralgia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Post herpetic Neuralgia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Type
10.2.1 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Distribution Channel
10.3.1 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2021)
10.3.2 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2022-2027)
10.3.3 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2016-2027)
10.4 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country
10.4.1 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Post herpetic Neuralgia Treatment Introduction
11.1.4 Pfizer Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Arbor Pharma
11.2.1 Arbor Pharma Company Details
11.2.2 Arbor Pharma Business Overview
11.2.3 Arbor Pharma Post herpetic Neuralgia Treatment Introduction
11.2.4 Arbor Pharma Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)
11.2.5 Arbor Pharma Recent Development
11.3 Assertio Therapeutics
11.3.1 Assertio Therapeutics Company Details
11.3.2 Assertio Therapeutics Business Overview
11.3.3 Assertio Therapeutics Post herpetic Neuralgia Treatment Introduction
11.3.4 Assertio Therapeutics Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)
11.3.5 Assertio Therapeutics Recent Development
11.4 Endo Pharma
11.4.1 Endo Pharma Company Details
11.4.2 Endo Pharma Business Overview
11.4.3 Endo Pharma Post herpetic Neuralgia Treatment Introduction
11.4.4 Endo Pharma Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)
11.4.5 Endo Pharma Recent Development
11.5 Teikoku Pharma
11.5.1 Teikoku Pharma Company Details
11.5.2 Teikoku Pharma Business Overview
11.5.3 Teikoku Pharma Post herpetic Neuralgia Treatment Introduction
11.5.4 Teikoku Pharma Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)
11.5.5 Teikoku Pharma Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Post herpetic Neuralgia Treatment Introduction
11.6.4 Teva Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)
11.6.5 Teva Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Post herpetic Neuralgia Treatment Introduction
11.7.4 Mylan Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)
11.7.5 Mylan Recent Development
11.8 Hengrui Medicine
11.8.1 Hengrui Medicine Company Details
11.8.2 Hengrui Medicine Business Overview
11.8.3 Hengrui Medicine Post herpetic Neuralgia Treatment Introduction
11.8.4 Hengrui Medicine Revenue in Post herpetic Neuralgia Treatment Business (2016-2021)
11.8.5 Hengrui Medicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140